These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 20729908)
101. Impact of the Tumor Microenvironment for Esophageal Tumor Development-An Opportunity for Prevention? Borgmann M; Quante M Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565378 [TBL] [Abstract][Full Text] [Related]
102. Hotspots and Frontiers in Inflammatory Tumor Microenvironment Research: A Scientometric and Visualization Analysis. Zhang Y; Huo L; Wei Z; Tang Q; Sui H Front Pharmacol; 2022; 13():862585. PubMed ID: 35370647 [No Abstract] [Full Text] [Related]
103. Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers. Lei MML; Lee TKW Front Cell Dev Biol; 2021; 9():692940. PubMed ID: 34235155 [TBL] [Abstract][Full Text] [Related]
104. Based on G-Series Mouse TH17 Array Study the Effect of Fluoride on C2C12 Cells Cytokines Expression. Zhu SQ; Zhou BH; Tan PP; Chai J; Yu YM; Wang HW Biol Trace Elem Res; 2021 Sep; 199(9):3402-3410. PubMed ID: 33244669 [TBL] [Abstract][Full Text] [Related]
106. Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL-17. Chen R; Chen QT; Dong YH Oncol Lett; 2019 Jun; 17(6):5447-5452. PubMed ID: 31186764 [TBL] [Abstract][Full Text] [Related]
107. The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients. Saleh ME; Gadalla R; Hassan H; Afifi A; Götte M; El-Shinawi M; Mohamed MM; Ibrahim SA PLoS One; 2019; 14(5):e0217550. PubMed ID: 31145753 [TBL] [Abstract][Full Text] [Related]
109. Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients. Lee MH; Tung-Chieh Chang J; Liao CT; Chen YS; Kuo ML; Shen CR Oncotarget; 2018 Feb; 9(11):9825-9837. PubMed ID: 29515773 [TBL] [Abstract][Full Text] [Related]
110. Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis. Li N; Xu W; Yuan Y; Ayithan N; Imai Y; Wu X; Miller H; Olson M; Feng Y; Huang YH; Jo Turk M; Hwang ST; Malarkannan S; Wang L Sci Rep; 2017 May; 7(1):1485. PubMed ID: 28469254 [TBL] [Abstract][Full Text] [Related]
111. SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes. Madonna S; Scarponi C; Morelli M; Sestito R; Scognamiglio PL; Marasco D; Albanesi C Oncotarget; 2017 Apr; 8(15):24652-24667. PubMed ID: 28445952 [TBL] [Abstract][Full Text] [Related]
112. Cancer immunotherapy: how low-level ionizing radiation can play a key role. Janiak MK; Wincenciak M; Cheda A; Nowosielska EM; Calabrese EJ Cancer Immunol Immunother; 2017 Jul; 66(7):819-832. PubMed ID: 28361232 [TBL] [Abstract][Full Text] [Related]
113. Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice. Kan X; Zhang W; You R; Niu Y; Guo J; Xue J BMC Complement Altern Med; 2017 Jan; 17(1):41. PubMed ID: 28086772 [TBL] [Abstract][Full Text] [Related]
114. Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type. Fabre J; Giustiniani J; Garbar C; Antonicelli F; Merrouche Y; Bensussan A; Bagot M; Al-Dacak R Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589729 [TBL] [Abstract][Full Text] [Related]
115. IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells. Merrouche Y; Fabre J; Cure H; Garbar C; Fuselier C; Bastid J; Antonicelli F; Al-Daccak R; Bensussan A; Giustiniani J Oncotarget; 2016 Aug; 7(33):53350-53361. PubMed ID: 27462789 [TBL] [Abstract][Full Text] [Related]
116. Decreased Anti-Tumor Cytotoxic Immunity among Microsatellite-Stable Colon Cancers from African Americans. Basa RC; Davies V; Li X; Murali B; Shah J; Yang B; Li S; Khan MW; Tian M; Tejada R; Hassan A; Washington A; Mukherjee B; Carethers JM; McGuire KL PLoS One; 2016; 11(6):e0156660. PubMed ID: 27310868 [TBL] [Abstract][Full Text] [Related]
117. LAP TGF-Beta Subset of CD4(+)CD25(+)CD127(-) Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients. Islas-Vazquez L; Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Galicia-Velasco M; Romero-Garcia S; Camacho-Mendoza C; Lopez-Gonzalez JS Biomed Res Int; 2015; 2015():430943. PubMed ID: 26582240 [TBL] [Abstract][Full Text] [Related]
118. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes. Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573 [TBL] [Abstract][Full Text] [Related]
119. Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis. Chen XW; Zhou SF Drug Des Devel Ther; 2015; 9():2941-6. PubMed ID: 26089643 [No Abstract] [Full Text] [Related]
120. Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer. Punt S; Houwing-Duistermaat JJ; Schulkens IA; Thijssen VL; Osse EM; de Kroon CD; Griffioen AW; Fleuren GJ; Gorter A; Jordanova ES Mol Cancer; 2015 Mar; 14():71. PubMed ID: 25889974 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]